In 2022, Regeneron paid Sanofi $900 million to gain full rights to its partnered cancer drug Libtayo. Three years later, the pricey bet on the injected PD-1 inhibitor appears to be paying off.

Jaxson Dart has some good news for Giants fans ahead of Thursday night's game against the rival Eagles. New York's rookie quarterback told reporters that he will face Philadelphia after showing up on ...

On the eve of the first game in the 2025 NLDS between the Philadelphia Phillies and the Los Angeles Dodgers, early analytical models give the NL West champions the slight edge. The Dodgers easily ...

On Wednesday, Baltimore Ravens star quarterback Lamar Jackson was spotted leaving practice 40 minutes early with a strength and conditioning coach, Jamison Hensley reports. “Ravens QB Lamar Jackson ...

"Walker seemingly teleported into the backfield to make a would-be tackle for loss on one play in Tuesday’s practice and then did it again to record a would-be sack on the next one," Pewter Report's ...

Ekman-Larsson left Saturday’s win in Edmonton with a lower-body injury. The Toronto Maple Leafs received some positive development Tuesday morning as defenseman Oliver Ekman-Larsson returned to ...

President Trump, in one of his first actions back in office, signed an executive order that moves the U.S. government toward designating drug cartels as terrorist organizations. The decision is part ...